Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PINPOINT: Gaming Technology to Engage Adolescent Sickle Cell Patients in Precision Pain Phase II

NCT04579926 is registered in ClinicalTrials.gov with Klein Buendel, Inc. as lead sponsor.

NCT NCT04579926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04579926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PINPOINT: Gaming Technology to Engage Adolescent Sickle Cell Patients in Precision Pain Phase II
Lead sponsor
Klein Buendel, Inc.
Phase
Not applicable
Overall status
Completed
Start date
September 19, 2018
Completion date
June 30, 2022
Enrollment
24 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell anemia in children, sickle cell disease, sickle cell sc disease, sickle cell thalassemia